BILLERICA, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, ...

Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards BILLERICA, Mass., Feb. 24, ...

BILLERICA, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (CFMS) (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, recently ...

BILLERICA, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced results of a ...

Knee replacements are a fact of aging. Conformis, a Boston-based medical tech company, produced personalized joint replacement for knees and hips. The goal is less pain and faster recoveries. Eicoff ...

ConforMIS expanded its Series E financing to $167.7 million, according to a News-Medical report. Participants include government investment funds, private equity funds and sovereign wealth funds in ...

BILLERICA, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that 90% of the patients studied in peer-reviewed clinical research published online in The Journal of ...

DURHAM, N.C. and BILLERICA, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. (NASDAQ: CFMS) announced today that they have entered into a definitive merger agreement under ...

KUSA - People have been getting knee replacement surgery for decades -- and 600,000 people will have the surgery this year alone. Now, there is a new personalized knee implant which is made ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Bedford medical device firm ConforMIS said recent studies ...